National HIV Surveillance System (NHSS)

The summary for the National HIV Surveillance System (NHSS) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
National HIV Surveillance System (NHSS): Executive Summary
The National HIV Surveillance System (NHSS) is the mechanism through which the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP), HIV Incidence and Case Surveillance Branch (HICSB) monitors trends in HIV infection diagnoses in the United States. Data collected on reported HIV cases are also used to estimate the prevalence and incidence of HIV infections, progression of disease after diagnosis, and receipt of care (based on laboratory tests after diagnosis). NHSS data guide public health action at federal, state, and local levels and help public health officials develop, implement, and evaluate HIV prevention programs (including efforts to prevent disease progression after diagnosis). Information on HIV infection and disease progression can be used to determine where HIV prevention services are most needed and ensure that persons living with HIV infection receive appropriate care. CDC-funded health departments report HIV case surveillance data to NHSS.

The CDC National HIV Prevention Program Monitoring and Evaluation (NHM&E) system provides data about CDC-funded HIV testing and other prevention activities conducted by CDC-funded health departments and community-based organizations. HIV testing is one of the DHAP core HIV prevention strategies. NHM&E testing data are used at federal, state and local levels to inform HIV prevention policy, program decision-making, and program monitoring and evaluation activities. Tracking persons newly diagnosed with HIV infection and their timely access to HIV medical care is important for CDC-funded HIV prevention programs.

This supplement is an expansion of activities under FOA CDC-RFA-PS13-1302. The purpose of the project is to improve the quality and completeness of CDC-funded HIV testing data through the sharing of data between the HIV surveillance program and the HIV prevention program at each health department. Health departments will implement strategies for sharing HIV testing and HIV case surveillance data between these two programs to improve the accuracy of data on new and pre-existing HIV diagnoses and linkage to HIV medical care among persons newly diagnosed with HIV infection.
Federal Grant Title: National HIV Surveillance System (NHSS)
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: CDC-RFA-PS13-13020401SUPP16
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.944
CFDA Descriptions: Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance
Current Application Deadline: Oct 5, 2015 Electronically submitted applications
Original Application Deadline: Oct 5, 2015 Electronically submitted applications
Posted Date: Aug 3, 2015
Creation Date: Aug 3, 2015
Archive Date: Nov 4, 2015
Total Program Funding: $1,200,000
Maximum Federal Grant Award: $120,000
Minimum Federal Grant Award: $20,000
Expected Number of Awards: 20
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Special district governments
City or township governments
State governments
Additional Information on Eligibility
Eligible Applicants: Competition is limited to jurisdictions currently funded under FOA CDC-RFA-PS13-1302 for HIV case surveillance (Component A) who met the following criteria for the collection and reporting of CD4 and viral load test results as of December 2014: The jurisdiction’s laws/regulations required the reporting of all CD4 and viral load results to the state/city health department. Laboratories that perform HIV-related testing for the jurisdictions had reported a minimum of 95% of HIV-related test results to the state/city health department. The jurisdiction had reported (to CDC) at least 95% of all CD4 and viral load test results received from January 2012 through September 2014.

The following jurisdictions may apply: Alabama, Alaska, Arkansas, California, Chicago; the District of Columbia; Hawaii; Houston; Illinois; Indiana; Iowa; Los Angeles; Louisiana; Maine; Maryland; Michigan; Missouri; Nebraska; New Hampshire; New York City; New York State; North Dakota; Oregon; San Francisco; South Carolina; South Dakota; Tennessee; Texas; Utah; Virginia; Washington; West Virginia; Wisconsin.
Link to Full Grant Announcement
Grant Announcement Contact
Levator Brown
Grants Policy

Centers for Disease Control and Prevention 770-488-2756
Similar Government Grants
Medical Monitoring Project (MMP)
National HIV Behavioral Surveillance (NHBS)
Medical Monitoring Project
Augmenting Laboratory Outcomes in HIV Assessment (ALOHA)
ADAPT: Adopting and Demonstrating the Adaption of Prevention Techniques - Supplement
Morbidity and Risk Behavior Surveillance
More Grants from the Centers for Disease Control and Prevention
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2 is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021